정밀의료용 공급망 물류 시장 : 규모, 점유율, 동향 분석 보고서 - 유형별, 서비스별, 온도 범위별, 용도별, 제품별, 최종 용도별, 지역별 부문 예측(2025-2030년)

Precision Medicine Supply Chain Logistics Market Size, Share & Trends Analysis Report By Type, By Service, By Temperature Range, By Application, By Product, By End-use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,269,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,659,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,438,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

정밀의료용 공급망 물류 시장 성장과 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 정밀의료용 공급망 물류 시장 규모는 2030년까지 141억 2,000만 달러에 이르며, 2025년부터 2030년까지의 CAGR은 11.36%를 나타낼 것으로 예측됩니다.

이 성장의 주요 요인은 급속한 기술 진보, 임상시험 수 증가, 정밀 의약품의 승인률의 향상, 엄격한 규제 프레임워크입니다.

정밀의료용 공급망 물류 산업의 성장은 고도로 전문화된 물류 솔루션이 필요한 맞춤형 의료에 대한 수요가 증가함에 따라 견인되고 있습니다. 이 솔루션은 복잡하고 섬세한 제품에 대응할 수 있는 엔드 투 엔드 공급망 관리 솔루션에 대한 요구를 높여주고 있습니다.

또한 물류 기능을 타사 공급업체에 아웃소싱하는 경향이 강해져 제약회사나 의료기관이 연구개발 및 시장개척 등의 핵심 역량에 집중할 수 있게 된 것도 시장의 성장을 지지하고 있습니다. 이 체인이 복잡해짐에 따라 아웃소싱은 물류를보다 효율적으로 관리하고 운영 비용을 줄이고 확장 성을 향상시키는 데 도움이 됩니다. 에의 규정 준수를 확보할 수 있는 전문적인 물류 서비스 수요를 한층 더 높이고 있습니다. 별개의 치료를 받는 환자에게 직접 배송을 관리하는 혁신적인 솔루션이 필요합니다.

시장 관계자에 의한 이니셔티브의 고조는 정밀의료용 공급망 물류의 전망을 형성하는데 있어 매우 중요한 역할을 하고 있습니다. 공급망의 효율성과 신뢰성을 높이기 위해 최첨단 기술과 인프라에 투자하고 있습니다. 협력 관계가 형성되고 있습니다. 기업은 엔드 투 엔드 가시성과 실시간 모니터링을 제공하여 공급망 전체의 투명성을 향상시키는 통합 물류 솔루션을 개발합니다. 예를 들어, 2025년 4월, GXO는 자사의 창고에서 인형 로봇을 테스트하는 프로그램을 시작하고, 고급 AI 주도의 자동화를 업무에 통합하는 것을 목표로 하고 있습니다. Robotics, Apptronik, Reflex Robotics의 로봇을 시험적으로 도입하고 있으며, 각각 컨테이너의 이동이나 자재의 재활용 등 특정 작업을 해내고 있습니다.

정밀의료용 공급망 물류 시장 보고서 하이라이트

• 유형별로는 임상분야가 2024년에 시장을 독점했습니다.
• 서비스별로는 운송분야가 2024년 시장을 독점했습니다.
• 온도 범위별로는 초저온이나 극저온을 필요로 하지 않는 세포 및 유전자 치료, 생물 제제, 재생 의료 제품에 대한 수요 증가에 의해 상온 보관이 2024년에 최대의 수익 점유율을 차지했습니다.
• 용도별로는 종양학 영역이 2024년에 정밀의료용 공급망 로지스틱스 업계를 지배했습니다.
• 제품별로는 세포 및 유전자 치료 분야가 2024년에 압도적인 수익 점유율을 차지했습니다.
• 최종 용도별로는 세포 및 유전자 치료, mRNA 베이스의 치료, 기타 고가치 생물 제제를 포함한 맞춤형 치료에 대한 주목의 고조에 의해 제약·바이오 의약품 기업이 2024년에 최대 시장 점유율을 차지했습니다.

목차

제1장 분석 방법·범위

제2장 주요 요약

제3장 정밀의료용 공급망 물류 시장 : 변동 요인, 동향 및 범위

• 시장 연관 전망
  • 상위 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 기술 상황
• 가격 모델 분석
• 업계·시장 분석 툴
  • Porter's Five Forces 분석
  • PESTEL 분석
  • COVID-19의 영향 분석

제4장 정밀의료용 공급망 물류 시장 : 유형별 추정 및 동향 분석

• 부문 대시보드
• 세계의 정밀의료용 공급망 물류 시장 : 변동 분석, 유형별
• 세계의 정밀의료용 공급망 물류 시장 : 규모와 동향 분석, 유형별(2018-2030년)
• 임상
• 상업

제5장 정밀의료용 공급망 물류 시장 : 서비스별 추정 및 동향 분석

• 부문 대시보드
• 세계의 정밀의료용 공급망 물류 시장 : 변동 분석, 서비스별
• 세계의 정밀의료용 공급망 물류 시장 : 규모와 동향 분석, 서비스별(2018-2030년)
• 운송
  • 항공화물
• 창고
• 조달 및 구매
• 기타

제6장 정밀의료용 공급망 물류 시장 : 온도 범위별 추정 및 동향 분석

• 부문 대시보드
• 세계의 정밀의료용 공급망 물류 시장 : 변동 분석, 온도 범위별
• 세계의 정밀의료용 공급망 물류 시장 : 규모와 동향 분석, 온도 범위별(2018-2030년)
• 상온 보관
• 냉장 보관
• 초저온 보관
• 극저온 보관

제7장 정밀의료용 공급망 물류 시장 : 용도별 추정 및 동향 분석

• 부문 대시보드
• 세계의 정밀의료용 공급망 물류 시장 : 변동 분석, 용도별
• 세계의 정밀의료용 공급망 물류 시장 : 규모와 동향 분석, 용도별(2018-2030년)
• 종양학
• 심장학
• 신경학
• 전염병
• 희귀질환
• 기타

제8장 정밀의료용 공급망 물류 시장 : 제품별 추정 및 동향 분석

• 부문 대시보드
• 세계의 정밀의료용 공급망 물류 시장 : 변동 분석, 제품별
• 세계의 정밀의료용 공급망 물류 시장 : 규모와 동향 분석, 제품별(2018-2030년)
• 세포 및 유전자 치료(CGT)
• 단일클론항체
• 핵산요법
• 백신
• 기타

제9장 정밀의료용 공급망 물류 시장 : 최종 용도별 추정 및 동향 분석

• 부문 대시보드
• 세계의 정밀의료용 공급망 물류 시장 : 변동 분석, 최종 용도별
• 세계의 정밀의료용 공급망 물류 시장 : 규모와 동향 분석, 최종 용도별(2018-2030년)
• 제약 및 바이오 의약품 기업
• 임상연구기관
• 기타

제10장 정밀의료용 공급망 물류 시장 : 지역별 추정 및 동향 분석

• 시장 점유율 분석 : 지역별(2024년, 2030년)
• 시장 대시보드 : 지역별
• 시장 규모 예측과 동향 분석(2018-2030년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 노르웨이
  • 스웨덴
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제11장 경쟁 구도

• 경쟁의 분류
  • 시장 리더
  • 신흥 기업
• 기업의 시장 점유율/평가 분석(2024년)
• 기업 프로파일
  • Almac Group
  • Catalent, Inc
  • Parexel International
  • IQVIA
  • Thermo Fisher Scientific
  • DHL
  • FedEx
  • UPS Healthcare
  • GXO Logistics
  • Marken

KTH

영문 목차

영문목차

Precision Medicine Supply Chain Logistics Market Growth & Trends:

The global precision medicine supply chain logistics market size is expected to reach USD 14.12 billion by 2030, growing at a CAGR of 11.36% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth is primarily attributed to the rapid technological advancements, the increasing number of clinical trials, higher approval of precision medicines, and a stringent regulatory framework. In addition, the increasing focus on regulatory compliance towards ensuring the products are handled safely and securely further boosting market growth.

The growth of the precision medicine supply chain logistics industry is driven by the rising demand for personalized medicine, which necessitates highly specialized logistics solutions. As healthcare shifts towards more individualized treatments, precision medicines such as gene therapies, biologics, and personalized drugs require tailored logistics solutions that ensure temperature-controlled transportation, regulatory compliance, and real-time tracking. This shift has created a growing need for end-to-end supply chain management solutions that can handle complex and sensitive products. Advanced technologies such as IoT-based tracking systems, temperature sensors, and blockchain for data transparency are becoming critical for maintaining the integrity of these products throughout the distribution process.

The market growth is also supported by the increasing trend of outsourcing logistics functions to third-party providers, enabling pharmaceutical companies and healthcare organizations to focus on core competencies such as R&D and product development. As the complexity of supply chains grows, outsourcing helps organizations manage logistics more effectively, reducing operational costs and improving scalability. Stringent regulatory requirements, particularly in handling biologics and genetic materials, further contribute to the demand for specialized logistics services that can ensure compliance with local and international regulations. Furthermore, the rise of e-commerce platforms and direct-to-consumer delivery models is expanding the scope of precision medicine logistics, requiring innovative solutions to manage the direct shipment of personalized therapies to patients. These factors are collectively driving the market growth, offering a substantial opportunity for logistics providers to capitalize on this emerging sector.

Rising initiatives by market players play a pivotal role in shaping the precision medicine supply chain logistics landscape. Leading logistics providers and pharmaceutical companies are investing in cutting-edge technologies and infrastructure to enhance the efficiency and reliability of supply chains for personalized treatments. Strategic partnerships and collaborations are being formed to address challenges related to temperature-sensitive shipments, regulatory compliance, and secure data handling. Companies are increasingly focusing on developing integrated logistics solutions that offer end-to-end visibility and real-time monitoring, improving overall supply chain transparency. For instance, in April 2025, GXO initiated a program to test humanoid robots in its warehouses, aiming to integrate advanced AI-driven automation into its operations. The company is currently piloting robots from Agility Robotics, Apptronik, and Reflex Robotics, each performing specific tasks such as moving containers and recycling materials.

Precision Medicine Supply Chain Logistics Market Report Highlights:

• Based on type, the clinical segment dominated the market in 2024, due to an increasing number of research and development activities by the market players, coupled with the growing number of precision medicine therapies in product pipelines.
• Based on service, the transportation segment dominated the market in 2024. The growth of is largely attributed to the rising demand for efficient, secure, and compliant transportation solutions capable of handling biologics, cell & gene therapies, and personalized medications.
• Based on temperature range, ambient storage held the largest revenue share in 2024 due to the increasing demand for cell & gene therapies, biologics, and regenerative medicine products that do not require ultra-low or cryogenic temperatures.
• Based on application, the oncology segment dominated the precision medicine supply chain logistics industry in 2024, due to the rapid adoption of advanced therapies for treating various cancers, particularly hematologic malignancies and solid tumors.
• Based on product, the cell & gene therapies segment held a dominant revenue share in 2024, due to the rapid advancements in personalized medicine and the increasing adoption of these therapies for a range of complex diseases.
• Based on end use, pharmaceutical and biopharmaceutical companies held the largest market share in 2024, due to the increasing focus on personalized therapies, including cell and gene therapies, mRNA-based treatments, and other high-value biologics.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Regional Scope
  • 1.1.2. Estimates and Forecast Timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Purchased Database
  • 1.3.3. GVR's Internal Database
  • 1.3.4. Secondary Sources
  • 1.3.5. Primary Research
• 1.4. Information or Data Analysis
  • 1.4.1. Information Analysis
  • 1.4.2. Market Formulation & Data Visualization
  • 1.4.3. Data Validation & Publishing
• 1.5. Model Details
  • 1.5.1. Commodity Flow Analysis (Model 1)
  • 1.5.2. Value-Chain-Based Sizing & Forecasting (Model 2)
  • 1.5.3. Multivariate Analysis (Model 3)
• 1.6. List of Secondary Sources
• 1.7. List of Abbreviations
• 1.8. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Precision Medicine Supply Chain Logistics Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising Adoption of Precision Medicine
    • 3.2.1.2. Increasing Clinical Trials for Personalized Therapeutics
    • 3.2.1.3. Regulatory Emphasis on Traceability and Quality Compliance
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Cost of Specialized Infrastructure and Operational Complexity
    • 3.2.2.2. Limited Standardization and Interoperability Across Supply Chains
• 3.3. Technology Landscape
• 3.4. Pricing Model Analysis
• 3.5. Industry Market Analysis Tools
  • 3.5.1. Porter's Five Forces Analysis
  • 3.5.2. PESTEL Analysis
  • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Precision Medicine Supply Chain Logistics Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Precision Medicine Supply Chain Logistics Market Type Movement Analysis
• 4.3. Global Precision Medicine Supply Chain Logistics Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 4.4. Clinical
  • 4.4.1. Clinical market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.5. Commercial
  • 4.5.1. Commercial market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Precision Medicine Supply Chain Logistics Market: Service Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Precision Medicine Supply Chain Logistics Market Service Movement Analysis
• 5.3. Global Precision Medicine Supply Chain Logistics Market Size & Trend Analysis, by Service, 2018 to 2030 (USD Million)
• 5.4. Transportation
  • 5.4.1. Transportation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.2. Air Freight
    • 5.4.2.1. Air Freight market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.2.2. Sea Freight
      • 5.4.2.2.1. Sea Freight market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.2.3. Overland
      • 5.4.2.3.1. Overland market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.5. Warehousing
  • 5.5.1. Warehousing market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.6. Sourcing & Procurement
  • 5.6.1. Sourcing & Procurement market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Precision Medicine Supply Chain Logistics Market: Temperature Range Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Precision Medicine Supply Chain Logistics Market Temperature Range Movement Analysis
• 6.3. Global Precision Medicine Supply Chain Logistics Market Size & Trend Analysis, by Temperature Range, 2018 to 2030 (USD Million)
• 6.4. Ambient Storage
  • 6.4.1. Ambient storage market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.5. Refrigerated Storage
  • 6.5.1. Refrigerated storage market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.6. Ultra-Low Temperature Storage
  • 6.6.1. Ultra-low temperature storage market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.7. Cryogenic Storage
  • 6.7.1. Cryogenic storage market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Precision Medicine Supply Chain Logistics Market: Application Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Precision Medicine Supply Chain Logistics Market Application Movement Analysis
• 7.3. Global Precision Medicine Supply Chain Logistics Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 7.4. Oncology
  • 7.4.1. Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.5. Cardiology
  • 7.5.1. Cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.6. Neurology
  • 7.6.1. Neurology market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.7. Infectious Diseases
  • 7.7.1. Infectious diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.8. Rare Diseases
  • 7.8.1. Rare diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.9. Others
  • 7.9.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Precision Medicine Supply Chain Logistics Market: Product Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Precision Medicine Supply Chain Logistics Market Product Movement Analysis
• 8.3. Global Precision Medicine Supply Chain Logistics Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 8.4. Cell & Gene Therapies (CGT)
  • 8.4.1. Cell & Gene Therapies (CGT) market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.5. Monoclonal Antibodies
  • 8.5.1. Monoclonal antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.6. Nucleic Acid Therapies
  • 8.6.1. Nucleic acid therapies market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.7. Vaccines
  • 8.7.1. Vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.8. Others
  • 8.8.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Precision Medicine Supply Chain Logistics Market: End Use Estimates & Trend Analysis

• 9.1. Segment Dashboard
• 9.2. Global Precision Medicine Supply Chain Logistics Market End Use Movement Analysis
• 9.3. Global Precision Medicine Supply Chain Logistics Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 9.4. Pharmaceutical and Biopharmaceutical Companies
  • 9.4.1. Pharmaceutical and biopharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
• 9.5. Clinical Research Organizations
  • 9.5.1. Clinical research organizations market estimates and forecasts, 2018 - 2030 (USD Million)
• 9.6. Others
  • 9.6.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 10. Precision Medicine Supply Chain Logistics Market: Regional Estimates & Trend Analysis

• 10.1. Regional Market Share Analysis, 2024 & 2030
• 10.2. Regional Market Dashboard
• 10.3. Market Size & Forecasts Trend Analysis, 2018 to 2030 (USD Million)
• 10.4. North America
  • 10.4.1. North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.4.2. U.S.
    • 10.4.2.1. Key country dynamics
    • 10.4.2.2. Competitive scenario
    • 10.4.2.3. Regulatory framework
    • 10.4.2.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.4.3. Canada
    • 10.4.3.1. Key country dynamics
    • 10.4.3.2. Competitive scenario
    • 10.4.3.3. Regulatory framework
    • 10.4.3.4. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.4.4. Mexico
    • 10.4.4.1. Key country dynamics
    • 10.4.4.2. Competitive scenario
    • 10.4.4.3. Regulatory framework
    • 10.4.4.4. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• 10.5. Europe
  • 10.5.1. Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.5.2. UK
    • 10.5.2.1. Key country dynamics
    • 10.5.2.2. Competitive scenario
    • 10.5.2.3. Regulatory framework
    • 10.5.2.4. UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.5.3. Germany
    • 10.5.3.1. Key country dynamics
    • 10.5.3.2. Competitive scenario
    • 10.5.3.3. Regulatory framework
    • 10.5.3.4. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.5.4. France
    • 10.5.4.1. Key country dynamics
    • 10.5.4.2. Competitive scenario
    • 10.5.4.3. Regulatory framework
    • 10.5.4.4. France market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.5.5. Italy
    • 10.5.5.1. Key country dynamics
    • 10.5.5.2. Competitive scenario
    • 10.5.5.3. Regulatory framework
    • 10.5.5.4. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.5.6. Spain
    • 10.5.6.1. Key country dynamics
    • 10.5.6.2. Competitive scenario
    • 10.5.6.3. Regulatory framework
    • 10.5.6.4. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.5.7. Denmark
    • 10.5.7.1. Key country dynamics
    • 10.5.7.2. Competitive scenario
    • 10.5.7.3. Regulatory framework
    • 10.5.7.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.5.8. Norway
    • 10.5.8.1. Key country dynamics
    • 10.5.8.2. Competitive scenario
    • 10.5.8.3. Regulatory framework
    • 10.5.8.4. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.5.9. Sweden
    • 10.5.9.1. Key country dynamics
    • 10.5.9.2. Competitive scenario
    • 10.5.9.3. Regulatory framework
    • 10.5.9.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• 10.6. Asia Pacific
  • 10.6.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.6.2. Japan
    • 10.6.2.1. Key country dynamics
    • 10.6.2.2. Competitive scenario
    • 10.6.2.3. Regulatory framework
    • 10.6.2.4. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.6.3. China
    • 10.6.3.1. Key country dynamics
    • 10.6.3.2. Competitive scenario
    • 10.6.3.3. Regulatory framework
    • 10.6.3.4. China market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.6.4. India
    • 10.6.4.1. Key country dynamics
    • 10.6.4.2. Competitive scenario
    • 10.6.4.3. Regulatory framework
    • 10.6.4.4. India market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.6.5. Australia
    • 10.6.5.1. Key country dynamics
    • 10.6.5.2. Competitive scenario
    • 10.6.5.3. Regulatory framework
    • 10.6.5.4. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.6.6. South Korea
    • 10.6.6.1. Key country dynamics
    • 10.6.6.2. Competitive scenario
    • 10.6.6.3. Regulatory framework
    • 10.6.6.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.6.7. Thailand
    • 10.6.7.1. Key country dynamics
    • 10.6.7.2. Competitive scenario
    • 10.6.7.3. Regulatory framework
    • 10.6.7.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• 10.7. Latin America
  • 10.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 10.7.2. Brazil
    • 10.7.2.1. Key country dynamics
    • 10.7.2.2. Competitive scenario
    • 10.7.2.3. Regulatory framework
    • 10.7.2.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.7.3. Argentina
    • 10.7.3.1. Key country dynamics
    • 10.7.3.2. Competitive scenario
    • 10.7.3.3. Regulatory framework
    • 10.7.3.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• 10.8. MEA
  • 10.8.1. MEA Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 10.8.2. South Africa
    • 10.8.2.1. Key country dynamics
    • 10.8.2.2. Competitive scenario
    • 10.8.2.3. Regulatory framework
    • 10.8.2.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.8.3. Saudi Arabia
    • 10.8.3.1. Key country dynamics
    • 10.8.3.2. Competitive scenario
    • 10.8.3.3. Regulatory framework
    • 10.8.3.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.8.4. UAE
    • 10.8.4.1. Key country dynamics
    • 10.8.4.2. Competitive scenario
    • 10.8.4.3. Regulatory framework
    • 10.8.4.4. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.8.5. Kuwait
    • 10.8.5.1. Key country dynamics
    • 10.8.5.2. Competitive scenario
    • 10.8.5.3. Regulatory framework
    • 10.8.5.4. Israel market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 11. Competitive Landscape

• 11.1. Competition Categorization
  • 11.1.1. Market Leaders
  • 11.1.2. Emerging players
• 11.2. Company Market Share/Assessment Analysis, 2024
• 11.3. Company Profiles
  • 11.3.1. Almac Group
    • 11.3.1.1. Company overview
    • 11.3.1.2. Financial performance
    • 11.3.1.3. Service benchmarking
    • 11.3.1.4. Strategic initiatives
  • 11.3.2. Catalent, Inc
    • 11.3.2.1. Company overview
    • 11.3.2.2. Financial performance
    • 11.3.2.3. Service benchmarking
    • 11.3.2.4. Strategic initiatives
  • 11.3.3. Parexel International
    • 11.3.3.1. Company overview
    • 11.3.3.2. Financial performance
    • 11.3.3.3. Service benchmarking
    • 11.3.3.4. Strategic initiatives
  • 11.3.4. IQVIA
    • 11.3.4.1. Company overview
    • 11.3.4.2. Financial performance
    • 11.3.4.3. Service benchmarking
    • 11.3.4.4. Strategic initiatives
  • 11.3.5. Thermo Fisher Scientific
    • 11.3.5.1. Company overview
    • 11.3.5.2. Financial performance
    • 11.3.5.3. Service benchmarking
    • 11.3.5.4. Strategic initiatives
  • 11.3.6. DHL
    • 11.3.6.1. Company overview
    • 11.3.6.2. Financial performance
    • 11.3.6.3. Service benchmarking
    • 11.3.6.4. Strategic initiatives
  • 11.3.7. FedEx
    • 11.3.7.1. Company overview
    • 11.3.7.2. Financial performance
    • 11.3.7.3. Service benchmarking
    • 11.3.7.4. Strategic initiatives
  • 11.3.8. UPS Healthcare
    • 11.3.8.1. Company overview
    • 11.3.8.2. Financial performance
    • 11.3.8.3. Service benchmarking
    • 11.3.8.4. Strategic initiatives
  • 11.3.9. GXO Logistics
    • 11.3.9.1. Company overview
    • 11.3.9.2. Financial performance
    • 11.3.9.3. Service benchmarking
    • 11.3.9.4. Strategic initiatives
  • 11.3.10. Marken
    • 11.3.10.1. Company overview
    • 11.3.10.2. Financial performance
    • 11.3.10.3. Service benchmarking
    • 11.3.10.4. Strategic initiatives

관련자료